Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02435550 · ClinicalTrials.gov registry record · NA

iCare for Cancer Patients

A NA study, sponsored by University of Florida.

Terminated
Registry status
NA
Development phase
136
Enrollment target

NCT02435550 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 136 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02435550, a NA study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.

Interventions

  • GENETIC Molecular diagnostic testing

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2015-06-26
Est. Completion 2019-10-01
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02435550

The ClinicalTrials.gov registry entry for NCT02435550 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Molecular diagnostic testing is the first listed.

NCT02435550 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02435550 about?

NCT02435550 is a clinical study titled "iCare for Cancer Patients". The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.

What is the current status of trial NCT02435550?

This trial is currently terminated. It is a NA study. The enrollment target is 136 participants. The study started on 2015-06-26. Estimated completion is 2019-10-01.

What interventions are being tested in trial NCT02435550?

The interventions under investigation include: Molecular diagnostic testing (GENETIC).

Who is sponsoring clinical trial NCT02435550?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.